Exhibit 99.1

 

Multiple Sclerosis Drug Development Information September 2021

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---

 

---